EGFR and neoplasm: Using primary tumor tissue, molecular studies of EGFR mutations, anaplastic lymphoma kinase fusion, and ROS proto-oncogene 1 fusion were performed using PNA-clamping-based polymerase chain reaction (PCR), fluorescent in situ hybridization, and reverse transcription PCR, respectively, before the initiation of frontline treatment.